Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Scroll Up
Scroll Down

The EU Definition of Nanomaterial – Potential Measurement Methodologies
Bookmark and Share

NanoSight Limited

In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.  

The definition has these principal elements:  

• Counting particles defines nanomaterials: The material is a nanomaterial if more than 50% of particles have at least one dimension between 1nm and 100nm.  

• Alternatively, it is also a nanomaterial if it has a specific surface per unit volume of greater than 60 m2/cm3.  

• There are specific inclusions such as graphene.  

• Naturally occurring and incidental materials are included, as well as manufactured particles.  

• Aggregates and agglomerates of such particles are included.  

No measurement methods are specified; the recommendation is ‘best available alternative methods should be applied. This definition is   not regulation, however its EU provenance informs its authority. For many regulators within the EU, this definition is the missing jigsaw piece to slot into potential regulation of publically-driven and government-derived legislation, covering nanomaterial matters from manufacture, labelling and handling, through transport and environmental fate. The FP7 project ObservatoryNANO describes current legislative work in their 4th report, April 2012. 

Further Information


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos